<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the treatment of primary and secondary immunodeficiency diseases, Kawasaki disease," exact="idiopathic thrombocytopenic purpura," post="and neurological diseases, such as Guillain–Barré syndrome, chronic inflammatory"/>
 <result pre="idiopathic thrombocytopenic purpura, and neurological diseases, such as Guillain–Barré syndrome," exact="chronic inflammatory demyelinating polyneuropathy," post="myasthenia gravis, polymyositis, multiple sclerosis, autoimmune encephalitis, and epilepsy"/>
 <result pre="neurological diseases, such as Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy," exact="myasthenia gravis," post="polymyositis, multiple sclerosis, autoimmune encephalitis, and epilepsy [ 1,"/>
 <result pre="as Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, polymyositis," exact="multiple sclerosis," post="autoimmune encephalitis, and epilepsy [ 1, 2]. Regardless of"/>
 <result pre="demyelinating polyneuropathy, myasthenia gravis, polymyositis, multiple sclerosis, autoimmune encephalitis, and" exact="epilepsy" post="[ 1, 2]. Regardless of age, disease, and severity"/>
 <result pre="1, 3, 5, 13, 14]. Several previous studies suggested that" exact="migraine" post="may be a risk factor for aseptic meningitis associated"/>
 <result pre="studies suggested that migraine may be a risk factor for" exact="aseptic meningitis" post="associated with IVIG [ 4, 15, 16]. Other studies"/>
 <result pre="suggested that migraine may be a risk factor for aseptic" exact="meningitis" post="associated with IVIG [ 4, 15, 16]. Other studies"/>
 <result pre="AE onset. Underlying diseases were divided into five categories: epilepsy," exact="central nervous system disease" post="(encephalitis/encephalopathy, cerebellitis, acute disseminated encephalomyelitis, and clinically isolated syndrome),"/>
 <result pre="onset. Underlying diseases were divided into five categories: epilepsy, central" exact="nervous system disease" post="(encephalitis/encephalopathy, cerebellitis, acute disseminated encephalomyelitis, and clinically isolated syndrome),"/>
 <result pre="into five categories: epilepsy, central nervous system disease (encephalitis/encephalopathy, cerebellitis," exact="acute disseminated encephalomyelitis," post="and clinically isolated syndrome), peripheral nervous system disease (including"/>
 <result pre="disease (encephalitis/encephalopathy, cerebellitis, acute disseminated encephalomyelitis, and clinically isolated syndrome)," exact="peripheral nervous system disease" post="(including chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, Miller–Fisher syndrome,"/>
 <result pre="(encephalitis/encephalopathy, cerebellitis, acute disseminated encephalomyelitis, and clinically isolated syndrome), peripheral" exact="nervous system disease" post="(including chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, Miller–Fisher syndrome,"/>
 <result pre="encephalomyelitis, and clinically isolated syndrome), peripheral nervous system disease (including" exact="chronic inflammatory demyelinating polyneuropathy," post="Guillain-Barré syndrome, Miller–Fisher syndrome, and myelitis), myasthenia gravis, and"/>
 <result pre="chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, Miller–Fisher syndrome, and myelitis)," exact="myasthenia gravis," post="and hypogammaglobulinemia. Three immunoglobulin preparations were used in this"/>
 <result pre="and 52.9% were male. The most common underlying disease was" exact="epilepsy" post="(66.3%). The median total dosage of IVIG was 1.08"/>
 <result pre="* Disease classification Epilepsy 69 19 * 50 * Central" exact="nervous system disease" post="† 12 5 7 Peripheral nervous system disease ‡"/>
 <result pre="* Central nervous system disease † 12 5 7 Peripheral" exact="nervous system disease" post="‡ 13 9 ** 4 ** Myasthenia gravis 8"/>
 <result pre="* * P &amp;lt; 0.01 ** P &amp;lt; 0.05 †Central" exact="nervous system disease" post="total number (number of adverse effects) = encephalitis/encephalopathy 8"/>
 <result pre="of adverse effects) = encephalitis/encephalopathy 8 (3), cerebellitis 2 (0)," exact="acute disseminated encephalomyelitis" post="1 (1) and clinically isolated syndrome 1 (1) ‡Peripheral"/>
 <result pre="effects) = encephalitis/encephalopathy 8 (3), cerebellitis 2 (0), acute disseminated" exact="encephalomyelitis" post="1 (1) and clinically isolated syndrome 1 (1) ‡Peripheral"/>
 <result pre="encephalomyelitis 1 (1) and clinically isolated syndrome 1 (1) ‡Peripheral" exact="nervous system disease" post="total number (number of adverse effects) = chronic inflammatory"/>
 <result pre="nervous system disease total number (number of adverse effects) =" exact="chronic inflammatory demyelinating polyneuropathy" post="7 (6), Guillain–Barré syndrome 3 (2), Miller–Fisher syndrome 1"/>
 <result pre="total number (number of adverse effects) = chronic inflammatory demyelinating" exact="polyneuropathy" post="7 (6), Guillain–Barré syndrome 3 (2), Miller–Fisher syndrome 1"/>
 <result pre="7 (6), Guillain–Barré syndrome 3 (2), Miller–Fisher syndrome 1 (0)," exact="myelitis" post="1 (0), and others 1 (0) BUN, blood urea"/>
 <result pre="2 0 Headache 15 6 12 11 3 1 Maculopapular" exact="rash" post="13 2 11 10 3 0 Vomiting 10 1"/>
 <result pre="AEs showed significant associations with older age, diseases such as" exact="epilepsy" post="and peripheral nervous system diseases, longer duration of IVIG"/>
 <result pre="g/kg for 2 – 5 days in cases of Guillain-Barré syndrome," exact="multiple sclerosis," post="myasthenia gravis, immune cytopenia, and immunoglobulin deficiency, and examined"/>
 <result pre="2 – 5 days in cases of Guillain-Barré syndrome, multiple sclerosis," exact="myasthenia gravis," post="immune cytopenia, and immunoglobulin deficiency, and examined changes in"/>
 <result pre="may have been underestimated because infants and some patients with" exact="epilepsy" post="or mental retardation would not have complained of subjective"/>
 <result pre="Sekul EA , Cupler EJ , Dalakas MC . Aseptic" exact="meningitis" post="associated with high-dose intravenous immunoglobulin therapy: frequency and risk"/>
 <result pre="score: Reliability and validation for pain assessment in children with" exact="cerebral palsy" post=". Scand J Pain. 2015; 9( 1): 57– 61."/>
</results>
